Patents-Review.com
ClassID:

116540 ⎘

C12Y302/01046 - CPC Classification

Classification description:

Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2); Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) Galactosylceramidase (3.2.1.46)

Recent Application in this class:
#1
20250375506
2025-12-11

CNS DELIVERY OF THERAPEUTIC AGENTS

 #2
20250228907
2025-07-17

COMPOSITIONS AND METHODS FOR TREATING METACHROMATIC LEUKODYSTROPHY DISEASE AND RELATED DISORDERS

 #3
20250161417
2025-05-22

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A

 #4
20250161221
2025-05-22

Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle

 #5
20250137012
2025-05-01

COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS

 #6
20250121040
2025-04-17

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

 #7
20240408020
2024-12-12

Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle

 #8
20230310652
2023-10-05

VLP FOR THE TREATMENT OF LEUKODYSTROPHIES

 #9
20230210941
2023-07-06

COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE

 #10
20230165942
2023-06-01

CNS DELIVERY OF THERAPEUTIC AGENTS

 #11
20230026836
2023-01-26

Methods and compositions for CNS delivery of iduronate-2-sulfatase

 #12
20220202718
2022-06-30

Cleavable lipids

 #13
20220133863
2022-05-05

TREATMENT OF SANFILIPPO SYNDROME TYPE B

 #14
20220133862
2022-05-05

Methods and compositions for CNS delivery of heparan N-sulfatase

 #15
20220118108
2022-04-21

COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE

 #16
20210395712
2021-12-23

OPTIMIZED GALC GENES AND EXPRESSION CASSETTES AND THEIR USE

 #17
20200405825
2020-12-31

Methods and compositions for CNS delivery of arylsulfatase A

 #18
20200237671
2020-07-30

Cleavable lipids

 #19
20200113981
2020-04-16

CNS delivery of therapeutic agents

 #20
20200046810
2020-02-13

Methods and compositions for CNS delivery of iduronate-2-sulfatase

 #21
20190336540
2019-11-07

TREATMENT OF KRABBE DISEASE WITH UMBILICAL CORD BLOOD TRANSPLANTION (UCBT) AND INCREASED GALACTOCEREBROSIDASE (GALC) EXPRESSION

 #22
20190314284
2019-10-17

Cleavable lipids

 #23
20190183984
2019-06-20

Methods and compositions for CNS delivery of heparan n-sulfatase

 #24
20180289777
2018-10-11

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

 #25
20180169020
2018-06-21

Cleavable lipids

 #26
20180112202
2018-04-26

PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC)

 #27
20180085438
2018-03-29

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety

 #28
20180071212
2018-03-15

Methods and compositions for CNS delivery of arylsulfatase A

 #29
20180008543
2018-01-11

Cleavable Lipids

 #30
20170042978
2017-02-16

CNS delivery of therapeutic agents

 #31
20160303205
2016-10-20

Combination Therapies for Lysosomal Storage Diseases

 #32
20160193304
2016-07-07

Process for concentration of a polypeptide

 #33
20150284698
2015-10-08

PURIFICATION OF RECOMBINANT HUMAN GALACTOCEREBROSIDE B-GALACTOSIDASE (rhGALC)

 #34
20150196014
2015-07-16

Animal model of Krabbe's disease

 #35
20140288160
2014-09-25

Cleavable lipids

 #36
20140044694
2014-02-13

Pharmaceutical composition for treating lysosomal storage disease

 #37
20130295077
2013-11-07

Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase

 #38
20130195835
2013-08-01

Microorganisms genetically engineered to have modified N-glycosylation activity

 #39
20130190253
2013-07-25

Microorganisms genetically engineered to have modified N-glycosylation activity

 #40
20120076767
2012-03-29

Process for concentration of a polypeptide

 #41
20110318324
2011-12-29

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASE

 #42
20110207676
2011-08-25

Microorganisms genetically engineered to have modified N-glycosylation activity

 #43
20110201540
2011-08-18

Glycosylation of molecules

 #44
20090246187
2009-10-01

PROCESS FOR CONCENTRATION OF A POLYPEPTIDE

 #45
20090069232
2009-03-12

and HAC1 nucleic acids